XML 59 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2011
Cash flow from operating activities:      
Net income $ 104,089,748 $ 100,694,443 $ 91,249,180
Adjustments to reconcile net income to net cash provided by operating activities:      
Amortization of intangible assets 1,365,473 1,698,241 1,949,444
Amortization of loan costs and discounts 612,021 311,624 441,895
Provision for loan losses 114,322,525 105,705,536 95,908,363
Amortization of convertible note discount 0 1,819,600 3,688,359
Depreciation 6,442,292 6,493,817 6,172,747
Deferred income tax benefit (10,941,998) (3,993,974) (2,837,480)
Compensation related to stock option and restricted stock plans 11,165,327 6,617,827 5,340,707
Unrealized gains on interest rate swap 0 (319,235) (1,017,032)
Change in accounts:      
Other assets, net (811,921) (490,705) 1,017,199
Income taxes payable 2,413,396 (1,575,266) (947,074)
Accounts payable and accrued expenses 3,387,226 2,439,394 (1,130,438)
Net cash provided by operating activities 232,044,089 219,401,302 199,835,870
Cash flows from investing activities:      
Increase in loans receivable, net (171,985,755) (167,224,562) (161,275,485)
Net assets acquired from office acquisitions, primarily loans (1,951,646) (3,383,421) (2,977,729)
Increase in intangible assets from acquisitions (716,169) (869,189) (746,666)
Purchases of property and equipment, net (6,884,296) (6,855,688) (6,394,287)
Net cash used in investing activities (181,537,866) (178,332,860) (171,394,167)
Cash flow from financing activities:      
Borrowings from lines of credit 443,515,466 405,020,000 293,895,000
Payments on lines of credit (272,515,466) (258,020,000) (310,795,000)
Repayment of convertible senior subordinated notes 0 (77,000,000) 0
(Payments on)/proceeds from junior subordinated note payable (50,000,000) 20,000,000 30,000,000
Proceeds from sale of the call option and warrants associated with the convertible notes 0 0 1,092,949
Proceeds from exercise of stock options 9,944,601 9,588,160 11,882,632
Repurchase of common stock (183,045,655) (139,799,981) (53,342,516)
Excess tax benefits from exercise of stock options 3,049,108 2,072,030 1,923,628
Net cash used in financing activities (50,036,946) (38,139,791) (25,972,355)
(Decrease) increase in cash and cash equivalents 469,277 2,928,651 2,469,348
Effects of foreign currency fluctuations on cash 387,912 (191,055) 116,064
Cash and cash equivalents at beginning of period 10,768,176 8,030,580 5,445,168
Cash and cash equivalents at end of period 11,625,365 10,768,176 8,030,580
Junior subordinated notes payable [Member]
     
Cash flow from financing activities:      
Payments of loan cost 0 0 (629,048)
Line of Credit [Member]
     
Cash flow from financing activities:      
Payments of loan cost $ (985,000) $ 0 $ 0